Cargando…

Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, which is causally related to the accumulation of abnormally folded amyloid-β (Aβ) peptide and hyperphosphorylated tau protein aggregates. The dendritic spine regulator Rho protein kinase 2 (Rock2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapresa, Rebeca, Agulla, Jesus, Gonzalez-Guerrero, Sonia, Bolaños, Juan P., Almeida, Angeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047900/
https://www.ncbi.nlm.nih.gov/pubmed/35496276
http://dx.doi.org/10.3389/fphar.2022.884470
_version_ 1784695824738942976
author Lapresa, Rebeca
Agulla, Jesus
Gonzalez-Guerrero, Sonia
Bolaños, Juan P.
Almeida, Angeles
author_facet Lapresa, Rebeca
Agulla, Jesus
Gonzalez-Guerrero, Sonia
Bolaños, Juan P.
Almeida, Angeles
author_sort Lapresa, Rebeca
collection PubMed
description Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, which is causally related to the accumulation of abnormally folded amyloid-β (Aβ) peptide and hyperphosphorylated tau protein aggregates. The dendritic spine regulator Rho protein kinase 2 (Rock2) accumulates in the brain at the earliest stages of AD and remains increased during disease progression. However, the molecular mechanism that upregulates Rock2 in AD, and its role in the disease progression, are unknown. Here, we found that oligomers of the amyloidogenic fragment 25–35 of the Aβ peptide (Aβ25-35) trigger Rock2 accumulation and activation in mouse cortical neurons in primary culture and in mouse hippocampus in vivo. Neuronal apoptotic death and memory impairment caused by Aβ25-35 administration were rescued by genetic and pharmacological inhibition of Rock2 activity. Mechanistically, Aβ25-35 elicited cyclin dependent kinase-5 (Cdk5)-mediated phosphorylation of Cdh1, a cofactor that is essential for the activity of the E3 ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) in neurons. Notably, phosphorylated Cdh1 was disassembled from the APC/C complex, causing its inactivation and subsequent Rock2 protein stabilization and activation. Moreover, Aβ25-35-induced neuronal apoptosis was prevented by expressing a phosphodefective form of Cdh1, but not by a phosphomimetic Cdh1. Finally, Cdh1 inactivation, using both genetic and pharmacological approaches, enhanced Aβ25-35-mediated neuronal death through a mechanism that was prevented by inhibition of Rock2 activity. These results indicate that the Cdk5-Cdh1 signaling pathway accounts for the increased Rock2 activity by amyloidogenic Aβ peptides and that this mechanism may contribute to neurodegeneration and memory loss in AD.
format Online
Article
Text
id pubmed-9047900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90479002022-04-29 Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration Lapresa, Rebeca Agulla, Jesus Gonzalez-Guerrero, Sonia Bolaños, Juan P. Almeida, Angeles Front Pharmacol Pharmacology Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, which is causally related to the accumulation of abnormally folded amyloid-β (Aβ) peptide and hyperphosphorylated tau protein aggregates. The dendritic spine regulator Rho protein kinase 2 (Rock2) accumulates in the brain at the earliest stages of AD and remains increased during disease progression. However, the molecular mechanism that upregulates Rock2 in AD, and its role in the disease progression, are unknown. Here, we found that oligomers of the amyloidogenic fragment 25–35 of the Aβ peptide (Aβ25-35) trigger Rock2 accumulation and activation in mouse cortical neurons in primary culture and in mouse hippocampus in vivo. Neuronal apoptotic death and memory impairment caused by Aβ25-35 administration were rescued by genetic and pharmacological inhibition of Rock2 activity. Mechanistically, Aβ25-35 elicited cyclin dependent kinase-5 (Cdk5)-mediated phosphorylation of Cdh1, a cofactor that is essential for the activity of the E3 ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) in neurons. Notably, phosphorylated Cdh1 was disassembled from the APC/C complex, causing its inactivation and subsequent Rock2 protein stabilization and activation. Moreover, Aβ25-35-induced neuronal apoptosis was prevented by expressing a phosphodefective form of Cdh1, but not by a phosphomimetic Cdh1. Finally, Cdh1 inactivation, using both genetic and pharmacological approaches, enhanced Aβ25-35-mediated neuronal death through a mechanism that was prevented by inhibition of Rock2 activity. These results indicate that the Cdk5-Cdh1 signaling pathway accounts for the increased Rock2 activity by amyloidogenic Aβ peptides and that this mechanism may contribute to neurodegeneration and memory loss in AD. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9047900/ /pubmed/35496276 http://dx.doi.org/10.3389/fphar.2022.884470 Text en Copyright © 2022 Lapresa, Agulla, Gonzalez-Guerrero, Bolaños and Almeida. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lapresa, Rebeca
Agulla, Jesus
Gonzalez-Guerrero, Sonia
Bolaños, Juan P.
Almeida, Angeles
Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title_full Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title_fullStr Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title_full_unstemmed Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title_short Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration
title_sort amyloid-β induces cdh1-mediated rock2 stabilization causing neurodegeneration
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047900/
https://www.ncbi.nlm.nih.gov/pubmed/35496276
http://dx.doi.org/10.3389/fphar.2022.884470
work_keys_str_mv AT lapresarebeca amyloidbinducescdh1mediatedrock2stabilizationcausingneurodegeneration
AT agullajesus amyloidbinducescdh1mediatedrock2stabilizationcausingneurodegeneration
AT gonzalezguerrerosonia amyloidbinducescdh1mediatedrock2stabilizationcausingneurodegeneration
AT bolanosjuanp amyloidbinducescdh1mediatedrock2stabilizationcausingneurodegeneration
AT almeidaangeles amyloidbinducescdh1mediatedrock2stabilizationcausingneurodegeneration